Compounds > 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and daunorubicin

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with daunorubicin in 5 studies

Compound Research Comparison

Studies
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Trials
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Recent Studies (post-2010)
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Studies
(daunorubicin)		Trials
(daunorubicin)		Recent Studies (post-2010) (daunorubicin)
38008,2398861,310

Protein Interaction Comparison

ProteinTaxonomy3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin (IC50)daunorubicin (IC50)
72 kDa type IV collagenaseHomo sapiens (human)1.9
Multidrug resistance-associated protein 1 Homo sapiens (human)8
Histone deacetylase 1Homo sapiens (human)0.047
Histone deacetylase 8Homo sapiens (human)0.22
Histone deacetylase 6Homo sapiens (human)0.02

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Begleiter, A; Johnston, JB; Pugh, L1
Marquardt, H; Mohr, U; Westendorf, J1
Acton, EM1
Groth, G; Marquardt, H; Steinheider, G; Westendorf, J1
Courseille, C; Dautant, A; Langlois D'estaintot, B; Mondon, M; Précigoux, G; Saminadin, P1

Reviews

1 review(s) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and daunorubicin

ArticleYear
Anthracycline mechanisms in analogue selection.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:1

    Topics: Animals; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Humans; Neoplasms, Experimental; Structure-Activity Relationship

1985

Other Studies

4 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and daunorubicin

ArticleYear
Cellular pharmacology of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin and structural analogues in human colon carcinoma HT-29 cells in vitro.
    Cancer research, 1987, Aug-01, Volume: 47, Issue:15

    Topics: Adenocarcinoma; Bacterial Proteins; Biological Transport; Cell Line; Cell Nucleus; Colonic Neoplasms; Daunorubicin; DNA Replication; Doxorubicin; Escherichia coli; Humans; RNA Polymerase I; Structure-Activity Relationship; Transcription, Genetic; Tumor Stem Cell Assay

1987
Induction of malignant transformation in vitro and mammary tumors in rats by two new potent anthracycline antitumor antibiotics, morpholinodaunomycin and cyanomorpholinoadriamycin.
    Cell biology and toxicology, 1987, Volume: 3, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Carcinogenicity Tests; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; Cricetulus; Daunorubicin; Doxorubicin; Female; In Vitro Techniques; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains

1987
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
    Cell biology and toxicology, 1985, Volume: 1, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats

1985
Release of the cyano moiety in the crystal structure of N-cyanomethyl-N-(2-methoxyethyl)-daunomycin complexed with d(CGATCG).
    European journal of biochemistry, 2000, Volume: 267, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Crystallography, X-Ray; Cyanides; Daunorubicin; DNA; Doxorubicin; Inhibitory Concentration 50; Leukemia L1210; Models, Molecular; Nucleic Acid Conformation

2000